Close Menu
Business Voice NowBusiness Voice Now
    Facebook X (Twitter) Instagram
    Business Voice NowBusiness Voice Now
    Subscribe
    • Markets
      • IPO
      • Market News
    • Business
      • FMCG
      • Retail
      • Quick Commerce
      • Startups
    • Healthcare
    • Technology
    • Energy
    • Voices
      • Entrepreneur – CXO Stories
      • Corporate Office story
    • E Magazine
      • Year 2026
        • November 2026
        • October 2026
        • September 2026
        • August 2026
        • July 2026
    Business Voice NowBusiness Voice Now
    Home»Business»Largest Contract Manufacturing Pharma Company Akums acquires Ankur Drugs and Pharma Ltd.’s HP plant to boost production capacities – Primex News Network
    Business

    Largest Contract Manufacturing Pharma Company Akums acquires Ankur Drugs and Pharma Ltd.’s HP plant to boost production capacities – Primex News Network

    By April 26, 2022No Comments3 Mins Read
    Share Facebook Twitter Pinterest LinkedIn Tumblr Email
    Follow Us
    Google News Flipboard Threads
    Share
    Facebook Twitter LinkedIn Pinterest Email

    New Delhi (India), April 26: Akums Drugs & Pharmaceuticals Ltd., the largest contract manufacturing pharmaceutical company in India, has recently acquired Ankur Drugs and Pharmaceuticals Ltd.’s facility based at Himachal Pradesh.

    Akums Drugs & Pharmaceuticals Ltd, the largest contract manufacturing pharmaceutical company in India, has recently acquired a facility from Ankur Drugs and Pharmaceuticals Limited. The facility acquired by Akums Drugs & Pharmaceuticals Ltd is one of largest drug manufacturing facilities in the country. With this acquisition Akums’ will boost its production capacities for general oral tablets and oral liquids. The planned capacities of the new facility are 6 billion units of tablets and 90 million units of oral liquids per annum. This facility is most likely to be fully operational by the end of 2022.

    Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sandeep Jain says, “What the addition of this new facility means to our existing network is to step up our continuous efforts to serve our customers efficiently and the nation better. We, at Akums, are already leading the market in many areas and, hence, we also know there is so much yet to be done. With this new facility in Nalagarh in Solan, Himachal Pradesh, we are trying to bridge some more capacity gaps in the pharma industry.”

    Founder, Promoter and Director, Akums Drugs & Pharmaceuticals, Shri Sanjeev Jain says, “In 2021, our supplies made up approximately 12% of the total market. With this new facility acquisition in the state of Himachal Pradesh and our previous acquisition in Kotdwar, Uttarakhand, in August 2021, we have bolstered our total capacity further. This expansion is a step towards achieving our goal of 20% market share. The operations at our Kotdwar plant have begun recently, while our new plant in Himachal Pradesh is likely to start its operations by December 2022.”

    Apart from these changes, Akums had also acquired three API facilities near Chandigarh in January 2021, all of which contribute to building its capacity and efficient backward-integrated supply chain to strengthen its market leader position in India, since Akums manufactures approximately 12% of all drugs consumed in the country.

    About Akums- Akums Drugs & Pharmaceuticals Ltd. is the largest contract manufacturing pharmaceutical company of India, manufacturing more than 12% of India’s consumption. The organisation deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. The company is currently supplying to almost all Indian and multinational pharmaceutical companies across the globe and is one of the largest employers. The 10 state-of-the-art facilities are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (injectable, eye, ear & nasal), hormonal (oral and injectable), ointments & cosmetics, Ayurvedic, food supplements & nutraceuticals and animal health care.

    In a span of few years, the organisation has become the icon of Indian pharmaceutical manufacturing industry and currently manufactures more than 12% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardised practices, Akums has been successful in attaining national and international accreditations, and building trust on the basis of efficacy, safety & quality. The organisation is certified with WHO-GMP, ISO 9001:2015, ISO 14001:2015 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi amongst others and exports to 53 countries across the world.

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

    Related Posts

    UGRO Capital’s Diwali campaign goes viral, recognizing entrepreneurs behind India’s success

    November 19, 2026

    Hamstech Invites Aspiring Designers to Explore Creative Careers Through Hamstech Design Entrance Test (HDET)

    November 19, 2026

    Consistent’s AAGO Unveils 98-Inch Interactive Display for Next-Generation Classrooms and Boardrooms

    November 19, 2026

    Comments are closed.

    Recent Post
    • Make Your Financial Plans Easier with a Personal Loan
    • Quest Alliance CEO Aakash Sethi Named to TIME100 Next: India, TIME’s Inaugural List of 100 Individuals Defining the Future of India
    • PPFAS Mutual Fund to host 13th unitholders’ meet on 21st November 2026
    • Vaccination and Surveillance Must Go Hand in Hand to Keep India Polio-Free
    • Happy Square Outsourcing Services Limited Announces H1 FY27 Results
    • Is your child’s polio vaccination schedule up to date?
    • Women’s Entrepreneurship Day 2026: Celebrating Women Who Lead
    • Women’s Entrepreneurship Day 2026: Celebrating Women Leading with Purpose

    Type above and press Enter to search. Press Esc to cancel.